Welcome to our dedicated page for Unitedhealth Gp SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UnitedHealth Group Incorporated filings document the formal disclosures of a large health care company organized around UnitedHealthcare and Optum. Proxy materials describe board governance, executive compensation, shareholder voting matters and the company’s complementary businesses: UnitedHealthcare health coverage and Optum clinical, data, product, pharmacy and care services.
Current reports on Form 8-K cover operating and financial results, Regulation FD communications, strategy and market-position discussions, director appointments, compensation arrangements and other material-event disclosures. The filing record also documents governance practices, capital-structure and compensation matters, risk-related business context and the regulatory reporting framework for a Delaware public operating company in the health care sector.
UnitedHealth Group reported first quarter 2026 revenues of $111.7 billion, up 2% year-over-year, with earnings from operations of $9.0 billion and net margin of 5.6%. Diluted earnings were $6.90 per share and adjusted earnings were $7.23 per share, both slightly above the prior year.
The medical cost ratio improved to 83.9%, down 90 basis points, while the operating cost ratio rose to 13.8% as the company invested in people, technology and modernization. Cash flows from operations were $8.9 billion, or 1.4 times net income, and the debt-to-capital ratio was 42.9% as of March 31, 2026.
Management raised its full year 2026 earnings outlook to greater than $17.35 per share and adjusted earnings to greater than $18.25 per share. During the quarter, UnitedHealth agreed to acquire Alegeus Technologies, completed the sale of the Optum UK business with $400 million in net proceeds committed to the United Health Foundation, and put in place an arrangement to repurchase at least $2.0 billion of common stock by the end of the second quarter 2026.
HOOPER MICHELE J reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Michele J. Hooper received a grant of 206 deferred stock units of common stock on April 1, 2026 as regular quarterly compensation for Board service. The units are immediately vested but must be held until her Board service ends, bringing her direct holdings to 41,792 shares/units. This is a routine compensation-related equity award rather than an open-market purchase or sale.
MCNABB FREDERICK WILLIAM III reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Frederick William McNabb III received a grant of 388 deferred stock units of common stock as regular quarterly compensation for Board service. These units are immediately vested but must be held until he completes his service on the Board, and his direct holdings after the award total 15,162 shares.
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Charles D. Baker received 343 deferred stock units of Common Stock as part of his regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board, bringing his direct holdings to 2,163 shares.
Gil Kristen reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Kristen Gil received 320 deferred stock units of common stock as regular quarterly compensation for Board service. These units are immediately vested but must be held until her Board service ends. Following this grant, she holds 2,403 shares directly and 3,800 shares indirectly through a trust.
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
Director John H. Noseworthy received a grant of 320 deferred stock units of UnitedHealth Group common stock as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be retained until he completes his service on the Board. Following this award, he directly holds 7,369 shares of common stock.
UnitedHealth Group director Paul R. Garcia reported routine equity compensation awards. On April 1, 2026, he acquired 206 deferred stock units and 137 shares of common stock as regular quarterly compensation for Board service. The deferred stock units are immediately vested but must be held until he completes Board service.
After these awards, Garcia directly holds 3,673 shares of UnitedHealth Group common stock. He also has indirect holdings through trusts, including 2,146 shares by a revocable trust, 45 shares by Trust 2, and 55 shares by Trust 3, reflecting additional beneficial interests reported in this filing.
Gottlieb Scott reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Scott Gottlieb received a grant of 320 deferred stock units of Common Stock as regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board. Following this award, he directly holds 446 shares/units in total.
MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Valerie Montgomery Rice, MD, received an award of 343 deferred stock units of common stock as regular quarterly compensation for Board service. The units are immediately vested but must be held until she completes her Board service. Following this grant, she directly holds 7,615 shares/units.
FLYNN TIMOTHY PATRICK reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Timothy Patrick Flynn received a grant of 350 shares of Common Stock-equivalent deferred stock units on April 1 as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be retained until he completes his service on the Board.
Following this grant, Flynn directly holds 10,589 shares of UnitedHealth Group common stock. In addition, an indirect holding entry reflects 6,033 shares held by a trust, indicating a separate ownership structure for part of his overall position.